Common Variation in the β-Carotene 15,15′-Monooxygenase 1 Gene Affects Circulating Levels of Carotenoids: A Genome-wide Association Study  by Ferrucci, Luigi et al.
ARTICLE
Common Variation in the b-Carotene
15,150-Monooxygenase 1 Gene Affects Circulating Levels
of Carotenoids: A Genome-wide Association Study
Luigi Ferrucci,1,* John R.B. Perry,4 Amy Matteini,5 Markus Perola,6 Toshiko Tanaka,1,7 Kaisa Silander,6
Neil Rice,4 David Melzer,4 Anna Murray,4 Christie Cluett,4 Linda P. Fried,8 Demetrius Albanes,9
Anna-Maria Corsi,10 Antonio Cherubini,11 Jack Guralnik,2 Stefania Bandinelli,12 Andrew Singleton,3
Jarmo Virtamo,13 Jeremy Walston,5 Richard D. Semba,14 and Timothy M. Frayling4
Low plasma levels of carotenoids and tocopherols are associated with increased risk of chronic disease and disability. Because dietary
intake of these lipid-soluble antioxidant vitamins is only poorly correlated with plasma levels, we hypothesized that circulating carot-
enoids (vitamin A-related compounds) and tocopherols (vitamin E-related compounds) are affected by common genetic variation. By
conducting a genome-wide association study in a sample of Italians (n ¼ 1190), we identiﬁed novel common variants associated
with circulating carotenoid levels and known lipid variants associated with a-tocopherol levels. Effects were replicated in the Women’s
Health and Aging Study (n ¼ 615) and in the a-Tocopherol, b-Carotene Cancer Prevention (ATBC) study (n ¼ 2136). In meta-analyses
including all three studies, the G allele at rs6564851, near the b-carotene 15,150-monooxygenase 1 (BCMO1) gene, was associated with
higher b-carotene (p ¼ 1.6 3 1024) and a-carotene (p ¼ 0.0001) levels and lower lycopene (0.003), zeaxanthin (p ¼ 1.3 3 105), and
lutein (p ¼ 7.3 3 1015) levels, with effect sizes ranging from 0.10–0.28 SDs per allele. Interestingly, this genetic variant had no signif-
icant effect on plasma retinol (p > 0.05). The SNP rs12272004, in linkage disequilibrium with the S19W variant in the APOA5 gene, was
associated with a-tocopherol (meta-analysis p ¼ 7.8 3 1010) levels, and this association was substantially weaker when we adjusted for
triglyceride levels (p ¼ 0.002). Our ﬁndings might shed light on the controversial relationship between lipid-soluble anti-oxidant nutri-
ents and human health.Introduction
There is evidence that genetic variation affects the produc-
tion and activity of antioxidant enzymes, such as super-
oxide dismutases (SOD), and self-synthesized antioxidant
molecules, such as glutathione.1,2 Whether genetic varia-
tion also affects the concentration and activity of extrinsic
dietary antioxidants, such as carotenoids and tocopherols,
has been little studied.
Carotene and structurally related compounds serve as
the precursors for vitamin A and play important roles in
the immune response, vision, and cellular differentiation.3
Plants are capable of de novo synthesis of a variety of carot-
enoid pigments, but animals need to get the essential
carotenoids from their diet and modify them through
a limited repertoire of metabolic transformations. The six
carotenoids most abundant in human serum are b-caro-
tene, a-carotene, b-cryptoxanthin, lycopene, lutein, and
zeaxanthin.4 In observational studies, high circulating
levels of carotenoids protect against age-related decline of
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The Americachronic morbidity.5–9 Thus, carotenoids are frequently
used as dietary supplements in the hope of maintaining
health and preventing diseases such as cancer and coro-
nary heart disease. Unfortunately, large clinical trials
have been unable to show beneﬁts for the formulations
tested, and some suggest that megadose supplementation
might be harmful10 For example, in the ATBC trial, admin-
istration of carotenoids to male smokers was associated
with excess risk of lung cancer.11–13 Other observational
studies show that a high intake of fruit and vegetables is
protective against inﬂammation, cardiovascular disease,
decline in physical performance, and mortality.14–21
Vitamin E comprises eight related tocopherols and toco-
trienols, which are fat-soluble vitamins with antioxidant
properties. a-tocopherol has the highest bioavailability
and is the most studied tocopherol. Many consider
a-tocopherol to be the most important lipid-soluble anti-
oxidant and claim that it protects cell membranes from
oxidation by reacting with lipid radicals produced in the
lipid peroxidation chain reaction.22 A low a-tocopherol
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correlates with frailty24 and poor cognitive function25 and
is linked with the characteristic mild proinﬂammatory
state often present in older persons.26
The correlation between vitamin intake assessed by die-
tary questionnaire and plasma levels is moderate for carot-
enoids27,28 and very poor for a-tocopherol.29 Interestingly,
changes in serum level after ingestion of a standard dose of
carotenoids is extremely variable between individuals but
relatively stable across multiple experiments conducted
in the same individual.30 Numerous factors inﬂuence
absorption, digestion, transportation, storage, chemical
transformation, and excretion of these compounds.31
Although few if any genetic studies attempting to identify
heritability in these processes have been performed, it is
reasonable to presume that genetic variation could affect
all these mechanisms.
In an attempt to identify genetic factors affecting carot-
enoids and tocopherol levels, we performed a genome-
wide association study (GWAS) of the participants of the
InCHIANTI study, which was conducted on a representa-
tive population in the Tuscany Chianti area (Italy). Main
ﬁndings were replicated in the Women’s Health and Aging
Study (WHAS), a study of disability in older women in Bal-
timore, MD, and the a-Tocopherol, b-Carotene Cancer
Prevention (ATBC) Study, a Finnish cancer-prevention trial
of a-tocopherol and b-carotene supplementation.Material and Methods
Sample Description
The InCHIANTI study is a population-based study of the older
population living in the Chianti region of Tuscany, Italy. The
details of the study have been previously reported.32 In brief,
1616 residents were selected from the population registry of two
small towns, Greve in Chianti and Bagno a Ripoli. The participa-
tion rate was 90% (n ¼ 1453), and the subjects ranged between
21 and 102 years of age. Overnight fasting blood samples were
utilized for genomic DNA extraction andmeasurement of caroten-
oids, tocopherols, and other chemicals. The study protocol was
approved by the Italian National Institute of Research and Care
of Aging Institutional Review.
Overall, 1307 participants donated a blood sample, and DNA
was extracted for 1242 of them. There were 85 parent-offspring
pairs, six sibling pairs, and two half-sibling pairs documented.
We investigated any further familial relationships by using
genome-wide SNP data and PLINK software and calculated an
inﬂation factor with PLINK software as previously described.33
All lambda inﬂation factors were very low (<1.06) and so did
not appreciably alter association statistics. We excluded individ-
uals who had less than 97% completeness in genotyping (n ¼
12) and who did not have measures of carotenoids and/or tocoph-
erols (n ¼ 39). To estimate the ethnicity of each of the InCHIANTI
samples, we used the ﬁrst principal components from the
EIGENSTRAT analysis of a set of 42,048 independent QC-ed
SNPs. This revealed that all individuals were of European ancestry.
The ﬁnal sample size was 1191.
We used data from two independent studies to replicate the
most signiﬁcant ﬁndings obtained in the InCHIANTI GWAS: The
ﬁrst study was the Women’s Health and Aging Studies (WHAS) I124 The American Journal of Human Genetics 84, 123–133, Februaryand II, which are companion studies of community-dwelling older
women andwere conducted in Baltimore.34WHAS Iwas a prospec-
tive cohort of women age 65 and older andwas designed to sample
the one-third of women who were most disabled in a 12-zip-code
area of Baltimore. After screening, 1,002 of 1,409 eligible women
consented to participate, and 78% of whom consented to baseline
blood draw. WHAS II sampled the two-thirds of women, age
70–79, who were the least disabled in the population. Four
hundred and four women in WHAS I and 211 in WHAS II were
of European ancestry and had DNA available.We performed statis-
tical analysis on WHAS I and II separately; we then meta-analyzed
the results and checked for heterogeneity between the two
branches of the study.
The second study population was a subset of the ATBC study,
a Finnish randomized controlled clinical trial of the effect of
b-carotene and a-tocopherol supplementation on cancer risk in
adult smokers. From 1985 to 1988, 29,133 male smokers aged 50
to 69 years were recruited from southwestern Finland (n ¼ 290
406) and randomized to one of four intervention regimens. The
individuals who participated in this study were a subset of 2136
participants in the placebo arm.12
Measures of retinol were also available from 362 participants of
European ancestry from the Baltimore Longitudinal Study of
Aging, conducted by the National Institute on Aging. Volunteers
age 20 years or older join the study for life. Extensive evaluations
are performed approximately every two years and include the
collection of a blood sample.
Study protocols of the InCHIANTI, BLSA, WHAS, and ATBC
studies complied with the Declaration of Helsinki and were
approved by the relevant institutional review boards. In all studies
eligible subjects consented to participate after receiving a compre-
hensive description of the survey procedures and risks associated
with them.Genotyping
In InCHIANTI and BLSA, genome-wide genotypingwas performed
with the Illumina InﬁniumHumanHap550 genotyping chip (chip
versions 1 and 3) as previously described.33 The exclusion criteria
for SNPs were minor allele frequency < 1% (n ¼ 25,422), genotyp-
ing completeness < 99% (n ¼ 23,610), and Hardy-Weinberg equi-
librium p < 0.0001 (n ¼ 517). We genotyped SNPs that reached
GWAS signiﬁcance in the InCHIANTI study in theWHAS by using
Taqman technology.35 Genotyped samples included 5% blind
duplicates, and genotypes were consistent across these duplicates.
All SNPs had a call rate > 98% and were in Hardy-Weinberg equi-
librium (p > 0.05). In the ATBC study, genotyping was performed
with Sequenom’s iPLEX chemistry according to the manufac-
turer’s protocol (Sequenom, San Diego, CA). The samples included
2% known duplicates, 5% blind duplicates, and 2%water controls.
Genotyping success rate was > 97% for all SNPs, and all were in
Hardy-Weinberg equilibrium (p > 0.05). Genotypes for all known
and blind duplicate pairs were consistent. Genotyping of APOA5
variants not captured on the Inﬁnium chip was performed in
the InCHIANTI samples with Taqman technology.Carotenoids and Tocopherols Assay
In all three studies blood samples were collected by venipuncture,
and aliquots of serum or plasma were stored at 70C and never
thawed before carotenoids and vitamin E assays. In both
InCHIANTI and WHAS, carotenoids, retinol, and tocopherols
were measured via high-performance liquid chromatography13, 2009
Table 1. Summary Details of Carotenoid and Tocopherol Levels
Study or Vitamin Measure Units N Mean (SD) Transformation Used Lambda Inflation Factor
InCHIANTI
b-carotene mmol/liter 1191 0.41 (0.27) Natural log 1.034
a-carotene mmol/liter 1191 0.057 (0.051) Natural log 1.018
b-cryptoxanthin mmol/liter 1191 0.21 (0.16) Natural log 1.018
Lycopene mmol/liter 1191 0.68 (0.33) Square rootb 1.03
Zeaxanthin mmol/liter 1191 0.063 (0.024) Natural logc 1.016
Lutein mmol/liter 1191 0.38 (0.15) Square-root 1.026
Retinol mmol/liter 1191 1.92 (0.50) Natural log 1.03
a-tocopherol mmol/liter 1191 33.44 (7.65) Noned 1.054
g-tocopherol mmol/l 1191 2.20 (0.96) Natural log 1.024
WHAS I
b-carotene mmol/liter 404 0.42 (0.38) Natural log N/A
a-carotene mmol/liter 404 0.099 (0.091) Natural log N/A
b-cryptoxanthin mmol/liter 404 0.14 (0.15) Natural log N/A
Lycopene mmol/liter 404 0.56 (0.31) None N/A
Zeaxanthin/ Lutein mmol/liter 404 0.34 (0.16) Square root N/A
Luteina mmol/liter 289 0.17 (0.08) Square root N/A
Zeaxanthina mmol/liter 289 0.066 (0.029) Square root N/A
Retinol mmol/liter 404 0.94 (0.35) Inverse normal N/A
a-tocopherol mmol/liter 404 23.42 (8.79) Natural log N/A
WHAS II
b-carotene mmol/liter 211 0.57 (0.54) Natural log N/A
a-carotene mmol/liter 211 0.143 (0.137) Natural log N/A
b-cryptoxanthin mmol/liter 211 0.16 (0.11) Natural log N/A
Lycopene mmol/liter 211 0.71 (0.34) None N/A
Zeaxanthin/ Lutein mmol/liter 211 0.43 (0.20) Square root N/A
Retinol mmol/liter 211 1.06 (0.36) Inverse normal N/A
a-tocopherol mmol/liter 211 24.25 (8.77) Natural log N/A
BLSA
Retinol ug/ml 362 0.63 (0.63) Inverse normal N/A
ATBC
b-carotenee mmol/liter 2126 0.40 (0.30) Natural log N/A
Retinol ug/liter 2136 585.5 (122.2) Inverse normal N/A
a-tocopherolf mmol/liter 2131 27.10 (7.22) Natural log N/A
N/A ¼ not available.
a Lutein and zeaxanthin separated in WHAS I, round 2.
b Square-root transformation was used for GWAS but none was used for meta-analysis purposes or presentation in Table 4.
c Natural-log transformation was used for GWAS, but square-root transformation was used for meta-analysis purposes and presentation in Table 4.
d No transformation was used for GWAS, but natural-log transformation was used for meta-analysis purposes and presentation in Table 4.
e Converted from mg/liter with the conversion factor of 53.27. mg/liter values were transformed and used in analyses, the results of which are in Table 2.
f Converted from mg/liter with the conversion factor of 44.17. mg/liter values were transformed and used in analyses, the results of which are in Table 4.(HPLC).36,37 Retinol concentration was also obtained from the
HPLC chromatogram. The method used in the InCHIANTI study
and in the WHAS subset evaluated at the 1-year follow-up allowed
for separate measures from lutein and zeaxanthin,36 whereas the
method used in WHAS at baseline (WHAS I) did not allow separa-
tion of the peaks for lutein and zeaxanthin.37 Within-run and
between-run coefﬁcients of variation were, respectively, 7.3%
and 9.6% for a-carotene, 4.5% and 5.4% for b-carotene, 2.7%
and 3.5% for b-cryptoxanthin, 2.6% and 7.1% for lutein,
6.2% and 6.8% for zeaxanthin, 7.5% and 7.8% for lycopene,
3.3% and 2.8% for retinol, 4.1% and 9.7% for a-tocopherol, and
5.1% and 6.9% for g-tocopherol. b-carotene, a-tocopherol, and
retinol were measured in baseline samples from the ATBC study
with a previously described reverse-phase liquid chromatographyThe Americamethod.38 In the BLSA, only an HPLC measure of retinol was
available.39Statistical Analysis
Measures of carotenoids and vitamin E were appropriately trans-
formed when non-normally distributed (see Table 1). For retinol
we used an inverse normal transformation in each study to allow
meta-analysis across studies that had used different units. Full
details of genome-wide association tests are previously
described.33 In brief, for each autosomal SNP for each of the
vitamin measures, we performed linear regression analyses by
using PLINK software with age and sex as covariates and assuming
additive allele effects with one degree of freedom. We checked forn Journal of Human Genetics 84, 123–133, February 13, 2009 125
Table 2. SNPs Associated with b-carotene at p < 5 3 107 in the InCHIANTI GWAS and Follow-up Results in the WHAS
and the ATBC Study
Study SNP Allelesa Chromosome MAF N Effect (95% Confidence Intervals)a Standard Error p Value
inCHIANTI rs6513787 C/A 20 0.08 1190 0.222 (0.306, 0.137) 0.043 3.6 3 107
inCHIANTI rs6420424 G/A 16 0.34 1191 0.152 (0.103, 0.201) 0.025 1.9 3 109
inCHIANTI rs8044334 T/G 16 0.24 1189 0.161 (0.106, 0.216) 0.028 1.3 3 108
inCHIANTI rs11645428 G/A 16 0.47 1190 0.118 (0.165, 0.072) 0.024 8.3 3 107
inCHIANTI rs6564851 T/G 16 0.36 1171 0.160 (0.112, 0.208) 0.024 9.7 3 1011
WHASc rs6513787 C/A 20 0.05 576 0.100 (0.307, 0.107) 0.106 0.34
WHASc rs6420424 G/A 16 0.49 602 0.165 (0.082, 0.248) 0.042 1.0 3 104
WHASc rs8044334 T/G 16 0.36 597 0.169 (0.084, 0.255) 0.044 1.1 3 104
WHASc rs11645428 G/A 16 0.33 599 0.196 (0.279, 0.113) 0.042 3.7 3 106
WHASc rs6564851 T/G 16 0.48 602 0.199 (0.116, 0.282) 0.042 2.6 3 106
ATBC rs6513787 C/A 20 0.04 2126 0.03 (0.13, 0.07) 0.05 0.13
ATBC rs6420424b G/A 16 N/A N/A N/A N/A N/A
ATBC rs8044334 T/G 16 0.35 2129 0.07 (0.034, 0.114) 0.02 0.0003
ATBC rs11645428 G/A 16 0.28 2129 0.12 (0.160, 0.075) 0.022 7.4 3 108
ATBC rs6564851 T/G 16 0.39 2108 0.13 (0.092, 0.171) 0.020 1.1 3 1010
Meta-analysis rs6513787 C/A 20 3892 0.136 (0.197, 0.075) 0.031 1.4 3 105
Meta-analysis rs6420424 G/A 16 1793 0.155 (0.11, 0.198) 0.022 6.5 3 1013
Meta-analysis rs8044334 T/G 16 3915 0.109 (0.079, 0.139) 0.015 9.3 3 1013
Meta-analysis rs11645428 G/A 16 3918 0.129 (0.159, 0.099) 0.015 1.5 3 1017
Meta-analysis rs6564851 T/G 16 3881 0.149 (0.120, 0.177) 0.015 1.6 3 1024
N/A ¼ not available, MAF ¼ minor allele frequency.
a Effect direction refers to second allele.
b rs6420424 failed genotyping in the ATBC study.
c Meta-analysis results of WHAS I and II are given.possible statistical over-inﬂation due to relatedness or residual
population admixture by using an inﬂation factor, generated
with EIGENSTRAT, for each trait (see Table 1).
We performed analysis of the WHAS, ATBC, and BLSA data
to mirror the analysis and replicate the major ﬁndings in the
InCHIANTI population. We carried out age- and sex-adjusted
multiple linear regressions that related each of the seven most
highly associated SNPs with each one of the vitamin measures
under an additive genetic model assumption. We performed
meta-analyses of results across different studies by weighting
each study with an inverse variance method as implemented in
STATAv10 (StataCorp. 2007. Stata Statistical Software: Release 10.
College Station, TX: StataCorp LP).
Results
Mean values of the major carotenoids and a-tocopherol
measured in the InCHIANTI, BLSA, and ATBC studies are
reported in Table 1. The results of the genome-wide associ-
ation study performed in the InCHIANTI samples for the
seven main carotenoids and the two main tocopherols,
limited to the SNPs that yielded association with a p <
1 3 105, are reported in Table S1 in the Supplemental
Data. Five SNPs were associated with b-carotene and/or
lutein plasma levels, and two SNPs were associated with
a-tocopherol with a p value < 5 3 107, a threshold value
previously used by other GWAS studies.40 There were no
associations at a p value < 5 3 107 for any of the other
six measures. Results were substantially unchanged when
the analysis was repeated with carotenoid levels averaged126 The American Journal of Human Genetics 84, 123–133, Februaryacross baseline and carotenoids measured at the 3 year
and 6 year follow-up instead of with only baseline values
(data not shown). Subsequent analyses focused on the
ﬁve SNPs associated with b-carotene or lutein plasma levels
and the two SNPs associated with a-tocopherol levels.
Of the SNPs associated with carotenoid levels, rs6513787
maps to chromosome 20, whereas rs6420424, rs8044334,
rs11645428, and rs6564851 all map to a 23 kb region of
chromosome 16 that includes the Polycystic kidney
disease 1-like 2 gene and is 7.7 kb 50 from the b-carotene
15,150-monooxygenase 1(BCMO1) gene. BCMO1 catalyzes
the ﬁrst step in the conversion of dietary provitamin carot-
enoids to vitamin A in the small intestine40–43 and so
represents an excellent candidate.
Of the SNPs associated with a-tocopherol levels,
rs12272004 maps to chromosome 11 close to the APOA5
gene and is highly correlated with the APOA5 coding
variant ‘‘S19W’’ (linkage disequilibrium r2 ¼ 0.88);
rs2903269 occurs on chromosome 4 more than100 kbp
from the nearest known gene.
We successfully genotyped seven SNPs in the WHAS
study (ﬁve at p < 5 3 107 with b-carotene levels and
two at p < 5 3 107 with a-tocopherol levels) and six
SNPs in the ATBC study (four at p < 5 3 107 with b-caro-
tene levels—rs6420424 could not be ﬁtted into the same
iPLEX pool as the others—and two at p < 5 3 107 with
a-tocopherol levels). Associations between the ﬁve carot-
enoid-relevant SNPs and b-carotene plasma levels across
the different studies are described in Table 2. Results for13, 2009
Figure 1. Associations between SNPs in and
around the BCMO1 Gene and b-Carotene Levels
Red triangles represent the –log10 p values from all
SNPs passing QC in the GWAS InCHIANTI study. The
stars represent the three-study meta-analysis p
values of the four SNPs taken forward into the repli-
cation studies.the four SNPs in or close to the BCMO1 gene on chromo-
some 16 (Figure 1) conﬁrmed a robust association with
b-carotene plasma levels in both the WHAS and ATBC
studies (Table 2). A meta-analysis across studies yielded p
values all lower than 1 3 1012. These four SNPs were all
in linkage disequilibrium with each other (r2 ranged from
0.22–0.55). The association between rs6513787 on chro-
mosome 20 and b-carotene levels was not replicated in
the WHAS (p ¼ 0.34) or ATBC (p ¼ 0.13) (Table 2).
TheSNP rs6564851 showed the strongest associationwith
plasma b-carotene; it had a p value of 1.6 3 1024 in the
meta-analysis, and participants with a G allele (the derived
allele; the Tallele is sharedwith chimps and other primates)
had an average b-carotene level 0.26 (0.18–0.34) standard
deviations (SD) higher than participants with a T allele.
Haplotype-basedanalysis, usingcombinationsof two, three,
and four SNPs from the BCMO1 region on chromosome 16,
did not reveal any associations stronger than those revealed
by single-SNP-based analyses: the best association was
between a two-SNP haplotype formed by rs6420424 and
rs6564851 (p ¼ 7.8 3 1011). The SNP rs6420424 showed
single-SNP effect sizes similar to those of rs6564851 but
was not genotyped in the large ATBC study, and so we
focused on rs6564851. The rs6564851 SNP was also signiﬁ-
cantly associated with plasma levels of other carotenoids
both in the InCHIANTI study and in WHAS (Table 3). The
G allele was associated with 0.28 (0.20–0.36) SD lower
lutein, 0.13 (0.05–0.21) SD higher a-carotene and, respec-
tively, 0.15 (0.07–0.23) and 0.10 (0.02–0.18) SD lower zeax-
anthin and lycopene. There was no evidence of association
between rs6564851 and either b-cryptoxanthin or retinol
in any of the individual studies or the meta-analysis.
Associations between the two a-tocopherol-related SNPs
and a-tocopherol plasma levels across the different studies
are described in Table 4. Results for rs12272004 conﬁrmed
a robust association with a-tocopherol plasma levels in
both theWHAS and the ATBC study (Table 4). Associations
between rs2903269 and a-tocopherol plasma levels did not
replicate. In the meta-analysis, the A allele of rs12272004The American Journal of Hwas associated with 0.07 SD higher a-tocoph-
erol, with a p value of 7.8 3 1010 (Table 4).
Because rs12272004 is highly correlated with
the S19W variant in the APOA5 gene, which is
known to alter chylomicrons and triglyceride
concentrations44, and because it is known
that vitamin E levels are strongly affected by
circulating lipids, we used InCHIANTI data toadjust the analysis for triglyceride levels. The strength of
the association was halved (p¼ 0.002, effect size on natural
loggeda-tocopherol levelsperAallele¼0.055 [0.02,0.091]).
Wenext examinedwhether other SNPspreviously shown
to alter lipid levels are associated with a-tocopherol levels
(Table 5).Weused the list of lipid variants reported in recent
genome-wide association studies.45 Where we had not
directly typed the relevant SNP as part of the GWAS, we
used a closely correlated ‘‘proxy’’ SNP. The association
between a SNP in strong linkage disequilibrium with the
APOA5 S19W variant and a-tocopherol levels led us to
directly type the second variant in this gene cluster known
to inﬂuence triglyceride levels, rs662799 (1131C/T). This
variant is not in strong linkage disequilibrium with
S19W46 and was not captured on the genome-wide chip.
We found evidence that three variants associated with
HD -cholesterol, two variants with LDL cholesterol, and
four variantswith triglycerideswere individually associated
with a-tocopherol levels (p < 0.05). By far the strongest
effects were between the two triglyceride-raising alleles in
the APOA5 gene cluster and raised a-tocopherol levels.
Discussion
By analyzing GWAS data from a representative sample of
the Italian population and conducting a replication study
with two other populations, we found that common vari-
ation near the gene encoding the enzyme b-carotene
15,150-monooxygenase (BCMO1) is highly associated
with plasma levels of several carotenoids. We also found
that the polymorphism rs12272004, a SNP that is highly
correlated with the S19W variant in the APOA5 gene,
signiﬁcantly affects plasma concentrations of a-tocoph-
erol. This effect is probably mediated or confounded by
increased circulating lipids.
Genetic Effect on Carotenoid Plasma Levels
The G allele of rs6564851 near the BCMO1 gene was asso-
ciated with signiﬁcantly higher b-carotene levels and, touman Genetics 84, 123–133, February 13, 2009 127
Table 3. Associations of rs6564851, the SNP Most Strongly Associated with b-Carotene, with Other Carotenoids and Retinol
Allelesb N Effect (95% Confidence Intervals) Standard Error p Value
InCHIANTI
a-carotene T/G 1171 0.089 (0.035, 0.143) 0.027 0.001
Lutein T/G 1171 0.033 (0.043, 0.024) 0.005 1.6 3 1011
Zeaxanthin T/G 1171 0.007 (0.011, 0.003) 0.002 3.3 3 104
Lycopene T/G 1171 0.033 (0.061, 0.006) 0.014 0.016
b-cryptoxanthin T/G 1171 0.0027 (0.032, 0.085) 0.030 0.37
Retinol T/G 1171 0.018 (0.005, 0.042) 0.012 0.13
WHAS
a-carotene T/G 602 0.091 (0.003, 0.185) 0.048 0.057
Luteina T/G 283 0.029 (0.044, 0.015) 0.007 0.0001
Zeaxanthina T/G 283 0.015 (0.024, 0.005) 0.005 0.003
Lycopene T/G 602 0.03 (0.063, 0.003) 0.017 0.07
b-cryptoxanthin T/G 602 0.021 (0.110, 0.068) 0.045 0.64
Lutein/Zeaxanthina T/G 602 0.038 (0.053, 0.023) 0.008 5.4 3 107
Retinol T/G 615 0.034 (0.067, 0.0001) 0.017 0.046
ATBC
Retinol T/G 2118 0.004 (0.014, 0.022) 0.009 0.66
BLSA
Retinol T/G 362 0.141 (0.0054-0.2869) 0.074 0.06
Meta-analysis
a-carotene T/G 1773 0.089 (0.043, 0.136) 0.024 0.0001
Lutein T/G 1454 0.032 (0.040, 0.024) 0.004 7.3 3 1015
Zeaxanthin T/G 1454 0.008 (0.012, 0.004) 0.002 1.3 3 105
Lycopene T/G 1773 0.032 (0.053, 0.011) 0.011 0.003
b-cryptoxanthin T/G 1773 0.012 (0.037, 0.061) 0.025 0.62
Retinol T/G 4266 0.007 (0.020, 0.006) 0.007 0.27
a In the baseline tests in WHASI and WHASII, lutein and zeaxanthin could not be separated upon assay. Separated lutein and zeaxanthin assays were
performed in WHAS I, round 2 follow-up only.
b Betas all refer to the rs6564851 G allele.a lesser extent, a-carotene plasma levels. The discovery In-
CHIANTI sample is likely to overestimate effect sizes, but
based on the larger of the two replication samples, ATBC,
rs6564851 explains 1.9% of the variance in b-carotene
levels. This effect size is large in comparison to the effects
conferred by common SNPs on other human traits such
as height47 and body-mass index48, although it is similar
to effect sizes seen for other circulating biomarkers.33 BasedTable 4. SNPs Associated with a-Tocopherol at p < 5 3 107 in
and ATBC Studies
Study SNP Alleles CHR MAF N
inCHIANTI rs12272004 C/A 11 0.05 117
inCHIANTI rs2903269 C/T 4 0.18 118
WHAS rs12272004 C/A 11 0.06 58
WHAS rs2903269 C/T 4 0.19 60
ATBC rs12272004 C/A 11 0.07 213
ATBC rs2903269 C/T 4 0.30 213
Meta-analysis rs12272004 C/A 11 389
Meta-analysis rs2903269 C/T 4 391
a Random-effects meta-analysis was used because of highly significant heter
128 The American Journal of Human Genetics 84, 123–133, Februaryon data from European individuals in HapMap, rs6564851
is in linkage disequilibrium with SNPs at r2 > 0.2 across
a region of 45 kbp stretching from 53 to 7 kbp 50 of the
BCMO1 gene. BCMO1 is a 15-150 dioxygenase that cata-
lyzes the ﬁrst step in the conversion of dietary provitamin
A carotenoids to vitamin A in the small intestine.41,42 Of
the carotenoids measured in our study, b-carotene, a-caro-
tene, and b-cryptoxanthin are considered potentialthe InCHIANTI GWAS and Follow-up Results in the WHAS
Effect Standard Error p Value
0 0.11(0.066, 0.15) 0.022 3.9 3 107
0 0.062(0.039, 0.085) 0.012 1.7 3 107
8 0.121(0.048, 0.194) 0.037 0.001
1 0.04(0.015, 0.095) 0.028 0.160
3 0.047(0.017, 0.077) 0.015 0.0019
0 0.009(0.014, 0.020) 0.009 0.76
1 0.072(0.049, 0.095) 0.012 7.8 3 1010
1 0.034(0.01, 0.08) 0.016 0.14a
ogeneity.
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Table 5. Effects of Known Lipid SNPs on a-Tocopherol Levels
SNP Nearest Gene(s) Allele Allele Frequency Genotyped Proxy SNP Used (r2) Effect (95% Confidence Intervals) p Value
HDL-Lowering Variants
rs4149268 ABCA1 C 0.27 0.32 (0.96 to 0.31) 0.32
rs1800775 CETP C 0.43 0.86 (1.49 to 0.23) 0.007
rs2144300 GALNT2 C 0.42 rs10779835 (0.97) 0.28 (0.89 to 0.33) 0.37
rs1800588 LIPC C 0.74 1.08 (1.82 to 0.34) 0.004
rs2156552 LIPG A 0.80 rs4939883 (0.95) 0.97 (1.88, 0.057) 0.04
rs328 LPL C 0.88 0.55 (1.41 to 0.31) 0.21
rs2238104 MVK-MMAB C 0.56 0.21 (0.83 to 0.42) 0.52
LDL-Raising Variants
rs693 APOB A 0.49 0.72 (0.11 to 1.33) 0.021
APOE 34 0.09 0.68 (0.58 to 1.93) 0.29
rs646776 CELSR2-PSRC1-SORT1 T 0.71 0.44 (0.34 to 1.22) 0.27
rs12654264 HMGCR T 0.42 rs6896136 (0.87) 0.31 (0.30 to 0.92) 0.32
rs6511720 LDLR G 0.10 1.23 (2.14 to 0.32) 0.008
rs11206510 PCSK9 T 0.85 0.49 (0.28 to 1.27) 0.21
Triglyceride-Raising Variants
rs1748195 ANGPTL3 C 0.68 rs1167998 (1.00) 0.69 (1.36 to 0.028) 0.041
rs662799 APOA1-C3-A4-A5 G 0.02 2.38 (0.05, 0.019) 7.3 3 107
rs3135506 APOA1-C3-A4-A5 G 0.06 rs12272004 (0.88) 2.94 (1.63 to 4.26) 1.2 3 105
rs693 APOB A 0.49 0.72 (0.11 to 1.33) 0.021
rs2144300 GALNT2 C 0.42 rs10779835 (0.97) 0.28 (0.33 to 0.89) 0.37
rs780094 GCKR T 0.38 0.28 (0.89 to 0.34) 0.38
rs328 LPL C 0.88 0.55 (1.41 to 0.31) 0.21
rs17145738 MLXIPL C 0.88 rs2240466 (1.00) 0.04 (1.13 to 1.22) 0.94
rs17321515 TRIB1 A 0.60 rs6982636 (1.00) 0.32 (0.95 to 0.30) 0.31vitamin A precursors because they contain at least one
unsubstituted b-ionone ring and a polyene side chain
attached with at least ﬁve conjugated double bonds
(Figure 2). The 15-150 central cleavage performed by
BCMO1 transforms one b-carotene molecule into two
molecules of retinal (Figure 3).41,42,49 The same reaction
can generate one molecule of retinal from each molecule
of a-carotene and b-cryptoxanthin (Figure 3). Given these
metabolic pathways, our ﬁndings suggest the G allele of
rs6564851, or an allele in strong linkage disequilibrium,
causes reduced BCMO1 activity, which results in higher
circulating levels of unconverted b-carotene and, to a lesser
extent, a-carotene. Consistent with this theory, in ourThe Americameta-analysis the effect of the G allele on b-cryptoxanthin
was slightly positive, although not statistically signiﬁcant.
The description of a rare missense mutation (threonine to
methionine) in BCMO1 is also consistent with our ﬁnd-
ings. This mutation silences as much as 90% of the
BCMO1 enzymatic activity and results in hypercarotenae-
mia and hypovitaminosis A.50 There is no strong evidence
that rs6564851 inﬂuences expression levels of the BCMO1
gene (p > 0.001), at least in lymphoblastoid cell lines, but
this is not surprising because BCMO1 expression is very
limited, if present at all, in lymphocytes.
In spite of the strong suggestion for reduced BCMO1
activity, we found no effect of rs6564851 on retinol plasmaFigure 2. Molecular Structure of Carot-
enoids Measured in the Study
b-carotene, a-carotene, and b-cryptoxan-
thin are considered potential vitamin A
precursors because they contain at least
one unsubstituted b-ionone ring and
a polyene side chain attached to at least
five conjugated double bonds. Note that
the portion of the molecule shaded in
gray is ‘‘equivalent’’ to retinol.
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Figure 3. BCMO1-Catalyzed Central Cleavage of b-Carotene Forms Two Molecules of Retinal, Whereas the Cleavage of a-Carotene
or b-cryptoxanthin Forms Only One Molecule of Retinal
Within the enterocytes, retinal is transformed into retinol, and then retinyl-esters, before being packed into nascent chylomicrons and
transported through the lymphatic system.concentration. This is not entirely surprising. The retinal
produced by the central cleavage of vitamin A precursors
is efﬁciently transformed to retinol by the retinaldehyde
reductase and esteriﬁed within enterocytes by lecithin:reti-
nol acyltransferase.51 Retinyl esters are transported by
nascent chylomicrons through the lymphatic system and
taken up by hepatocytes, where they are rehydrolyzed
into retinol and then either secreted by hepatocytes into
the circulation or stored in hepatic stellate (Ito) cells, in
a ratio aimed at maintaining a stable retinol plasma level.49
Thus, plasma retinol level is not a sensitive indicator of
vitamin A and only changes when liver reserves of vitamin
A are severely depleted. Future studies should quantify the
effect of rs6564851 on vitamin A status by using isotope
dilution techniques to measure total body stores of
vitamin A.52 The effect of the rs6564851 polymorphism
may be particularly important in persons who are at high
risk of vitamin A deﬁciency; such persons include individ-
uals with cystic ﬁbrosis and malabsorption syndromes and
preschool children in developing countries.53
A puzzling ﬁnding of this study is that participants with
a G allele in rs6564851 had signiﬁcantly lower levels of
lycopene, lutein, and zeaxanthin plasma concentrations.
Lycopene, lutein and zeaxanthin are synthesized only by
plants and mammals need to consume them in their
diet. Because of their molecular structure, there is no
reason to believe that these carotenoids are a direct target
for BCMO1. However, it has been proposed that caroten-130 The American Journal of Human Genetics 84, 123–133, Februaryoids antagonize absorption of each other, suggesting that
uptake by intestinal cells is a protein-transport facilitated
process.54 Thus, it may be hypothesized that, through
a still-unknown mechanism, higher a- and b-carotene
plasma levels directly affect absorption, cell transport,
and bio-availability of other carotenoids that are not
vitamin A precursors.
The G allele of rs6564851, or some other allele in strong
linkage disequilibrium, may affect health negatively by
reducing the availability of vitamin A but also positively
by increasing the plasma concentration of powerful anti-
oxidant molecules. A number of studies have shown that
higher plasma concentrations of antioxidant carotenoids
are associated in a protective manner against the develop-
ment of chronic diseases and disability.5–9 Future studies in
large representative populations should test the hypothesis
that long-term exposure to higher carotenoid concentra-
tions caused by the rs6564851 G allele is associated with
lower risk of health-related outcomes, including lower
risk of cancer, cardiovascular disease, and physical
disability. There was no association between the
rs6564851 G allele and grip strength (p ¼ 0.42, N ¼ 983)
or walk speed (p ¼ 0.47, N ¼ 705) in the InCHIANTI study,
but larger studies are likely to be needed to demonstrate
such an association. The variant rs6564851 is not captured
well by SNPs available in the publicly available WTCCC
data—the best proxy, rs7199144, has an r2 of 0.47 with
rs6564851 in European samples and is not associated13, 2009
with any of the seven diseases studied as part of the
WTCCC project (p > 0.05).
Genetic Effect on a-Tocopherol Plasma Levels
We found that the A allele of rs12272004 was strongly and
consistently associated with higher plasma a-tocopherol
levels. Vitamin E is a fat-soluble vitamin synthesized by
plants, and its intake depends strictly on dietary content.
Vitamin E absorption and distribution follows processes
similar to those utilized during fatty acid digestion and
metabolism. Vitamin E molecules enter enterocytes
through lipid-richmicelles and are packaged into chylomi-
crons in combination with high-density lipoproteins and
low-density lipoproteins and released into circulation.
Because known variants of the APOA5 gene cause hypertri-
glyceridemia and hyperchylomicronemia,44 it is not
surprising that the rs12272004 SNP, which is highly corre-
lated with the S19WAPOA5 SNP, appears to affect tocoph-
erol levels. This is consistent with previous data showing
that, in type 2 diabetes, a polymorphism of the APOA5
gene (rs662799 T/C) affects both VLDL triglycerides and
tocopherol plasma levels.55 Also consistent with our inter-
pretation, many of the SNPs that in the literature were
found to affect circulating lipids were signiﬁcantly associ-
ated with a-tocopherol levels in our study. Finally, after
we adjusted our analysis for triglycerides, the association
was substantially attenuated. Our data add to the literature
by showing that the effect of APOA5 on a-tocopherol is not
limited to diabetic patients and that APOA5 rs2272004 has
one of the strongest genetic effects on a-tocopherol levels
across the genome. The effect is speciﬁc for a-tocopherol
and does not include g-tocopherol. However, the concen-
tration of g-tocopherol is much higher than that of
a-tocopherol, and the resulting lower precision and reli-
ability of the measure may have affected our ﬁndings.
Projecting the effect of rs2272004 on health is difﬁcult.
Elevation in circulating triglycerides increases cardiovas-
cular risk, but an incremented level of a-tocopherol may
have a beneﬁcial effect. For example, we have previously
demonstrated that high a-tocopherol levels are protective
against disability and frailty in the older population.23
Conclusions
In this study we found strong evidence that common poly-
morphisms near the BCMO1 gene are associated with
substantial and signiﬁcant increases in antioxidant carot-
enoid plasma levels. It is likely that the same genetic vari-
ation also affects vitamin A synthesis, although this effect
could not be conﬁrmed with the methodology used in our
study and should be tested in future research. We also
found that a SNP close to the APOA5 gene is associated
signiﬁcantly with differential levels of a-tocopherol,
possibly because of its effect on circulating triglycerides
and chylomicrons. Curiously, in both cases the identiﬁed
SNPs affect human health in ways that are both potentially
positive and negative. Whether positive or negative
aspects prevail should be tested in the context of futureThe Americalongitudinal studies. Finally, the common variants associ-
ated with carotenoid levels could be used in Mendelian
randomization studies,56 that aim to dissect the causal
directions of associations between carotenoid levels and
secondary phenotypes.
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